Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Experimental: Baofukang Suppository 7 days, Experimental: Baofukang Suppository 14 days.
- Who it may be relevant to
- Registry conditions: Vaginitis. Basic parameters: 18 years — 55 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Medical Ethics Committee of Peking University Shenzhen Hospital
Overview
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.
Detailed description
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.
Group 1: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 7 days.
Group 2: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 14 days.
The efficacy and safety will be evaluated 7\~14 days after treatment and 35\~42 days after treatment.
Interventions
- Drug Experimental: Baofukang Suppository 7 days
Experimental: Baofukang Suppository 7 days - Drug Experimental: Baofukang Suppository 14 days
Experimental: Baofukang Suppository 14 days
Primary outcome measures
- Cure rate [Time frame: First week after treatment]
- Cure rate [Time frame: First month after the treatment]
Secondary outcome measures (1)
- Side affect [Time frame: First week after treatment]
Eligibility criteria
Inclusion criteria
Aerobic vaginitis diagnosed based on present ：
- Vaginal dischareg ;
- pH > 4.5;
- Donders score≥3;
Exclusion criteria
- Patients with other vaginitis, cervical erosion, or suspected gonorrhea, herpes simplex virus infection and other vulvar diseases;
- Patients received systemic or vaginal antifungal or antibiotic treatment within two weeks before admission.
- Pregnancy, lactation and intentional pregnancy;
- Women with liver and kidney dysfunction, low immune function, diabetes, psychosis or other serious diseases;
- Allergic constitution and patients allergic to drug ingredients in this study;
- Those with poor compliance.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
China · 1 center
- Peking University Shenzhen Hosptal — Shenzhen
Identifiers
NCT: NCT04574089 · PUShenzhenH